mRNA as a Novel Treatment Strategy for Hereditary Spastic Paraplegia Type 5

Hauser, Stefan; Poenisch, Marion; Schelling, Yvonne; Hoeflinger, Philip; Schuster, Stefanie; Teegler, Axel; Betten, Rabea; Gustafsson, Jan-Ake; Huebener-Schmid, Jeannette; Schlake, Thomas; Chevessier-Tuennesen, Frederic; Horscroft, Nigel; Bjorkhem, Ingemar; Schoels, Ludger

dc.contributor.author	Hauser, Stefan
dc.contributor.author	Schelling, Yvonne
dc.contributor.author	Höflinger, Philip
dc.contributor.author	Schuster, Stefanie
dc.contributor.author	Hübener-Schmid, Jeannette
dc.contributor.author	Schöls, Ludger
dc.date.accessioned	2020-07-09T12:18:44Z
dc.date.available	2020-07-09T12:18:44Z
dc.date.issued	2019
dc.identifier.issn	2329-0501
dc.identifier.uri	http://hdl.handle.net/10900/102530
dc.language.iso	en	de_DE
dc.publisher	Cell Press	de_DE
dc.relation.uri	http://dx.doi.org/10.1016/j.omtm.2019.10.011	de_DE
dc.subject.ddc	610	de_DE
dc.title	mRNA as a Novel Treatment Strategy for Hereditary Spastic Paraplegia Type 5	de_DE
dc.type	Article	de_DE
utue.quellen.id	20200409032300_00073
utue.publikation.seiten	359-370	de_DE
utue.personen.roh	Hauser, Stefan
utue.personen.roh	Poenisch, Marion
utue.personen.roh	Schelling, Yvonne
utue.personen.roh	Hoeflinger, Philip
utue.personen.roh	Schuster, Stefanie
utue.personen.roh	Teegler, Axel
utue.personen.roh	Betten, Rabea
utue.personen.roh	Gustafsson, Jan-Ake
utue.personen.roh	Huebener-Schmid, Jeannette
utue.personen.roh	Schlake, Thomas
utue.personen.roh	Chevessier-Tuennesen, Frederic
utue.personen.roh	Horscroft, Nigel
utue.personen.roh	Bjorkhem, Ingemar
utue.personen.roh	Schoels, Ludger
dcterms.isPartOf.ZSTitelID	Molecular Therapy - Methods & Clinical Development	de_DE
dcterms.isPartOf.ZS-Volume	15	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE